3SBIO INC Ord Shs TRSBF

Now down to a p/e of just 1.8x !!

[theinvestor22]

It's hard to believe that SSRX is trading at such a low p/e.  Here's the calculation:

(Current price of $5.84/ADS less cash of $4.89/ADS) divided by trailing twelve month fully diluted earnings per share of $.521 = 1.8

If you check my last few postings relating to the company's growth profile, you'll form an impression of just how undervalued the company is.

Yes, part of the $4.89/ADS in cash will be used to complete the new large plant (now under construction), but the result of that will be much improved earnings.  I would think that the company will start buying back shares under its previously announced program soon, if it hasn't done so already.  Also, in today's market environment, acquisitions must be starting to look pretty good.

Speaking of markets, their current nadir is pushing down prices of some wonderful growth companies in China that won't be materially affected by a potential recession in the west..  In my own portfolio, I have this and three other Chinese pharmas - CSKI (Nasdaq), SVA (AMEX) and DDD (TSX) - plus the Chinese consulting firm YTEC (Nasdaq).  I can't see how any of them will be affected by world events, yet they're all priced quite low.  My other Chinese company - SDTH (Nasdaq) - is selling all it can produce.

Oh well, nothing to do but sit back and watch the circus.